Sight Sciences (NASDAQ:SGHT – Get Free Report) and Medite Cancer Diagnostics (OTCMKTS:MDIT – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Profitability This table compares Sight Sciences and […]
Sight Sciences (NASDAQ:SGHT – Get Free Report) and Medite Cancer Diagnostics (OTCMKTS:MDIT – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk. Valuation & Earnings This table compares Sight […]
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Recommendation of "Hold" from Analysts etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) saw a significant drop in short interest in November. As of November 15th, there was short interest totalling 969,700 shares, a drop of 20.5% from the October 31st total of 1,220,000 shares. Based on an average daily volume of 449,400 shares, the days-to-cover ratio is presently 2.2 […]
Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) was the target of a significant increase in short interest in October. As of October 15th, there was short interest totalling 1,040,000 shares, an increase of 47.7% from the September 30th total of 704,000 shares. Based on an average daily volume of 234,900 shares, the short-interest ratio […]